Elia, Josephine
Ungal, Grace
Kao, Charlly
Ambrosini, Alexander
De Jesus-Rosario, Nilsa
Larsen, Lene
Chiavacci, Rosetta
Wang, Tiancheng
Kurian, Christine
Titchen, Kanani
Sykes, Brian
Hwang, Sharon
Kumar, Bhumi
Potts, Jacqueline
Davis, Joshua
Malatack, Jeffrey
Slattery, Emma
Moorthy, Ganesh
Zuppa, Athena
Weller, Andrew
Byrne, Enda
Li, Yun R.
Kraft, Walter K. http://orcid.org/0000-0002-5074-0141
Hakonarson, Hakon
Article History
Received: 18 January 2017
Accepted: 15 November 2017
First Online: 16 January 2018
Competing interests
: H.H. is the founder of NeuroFix, served on its Advisory Board and has stock or equity in neuroFix Therapeutics LLC, which is now owned by Aevi Genome Medicine Inc. H.H. was not involved with the evaluation of the study participants. All of the clinical evaluations were performed by J.E. and W.K.K. and their staff, none of whom have any competing interests, or any affiliation with neuroFix. All of the statistical analysis was done based on a predesigned SAP by an independent statistician as work for hire from a locked database. The remaining authors declare no competing financial interests.